9780199592548

Oxford Textbook of Clinical Nephrology

by ; ; ; ; ; ;
  • ISBN13:

    9780199592548

  • ISBN10:

    0199592543

  • Edition: 4th
  • Format: Package
  • Copyright: 2015-12-22
  • Publisher: Oxford University Press

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

  • Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $750.00 Save up to $75.00
  • Rent Book $675.00
    Add to Cart Free Shipping

    TERM
    PRICE
    DUE

Supplemental Materials

What is included with this book?

  • The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
  • The Rental copy of this book is not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Summary

This fourth edition of the Oxford Textbook of Clinical Nephrology builds on the success and international reputation of the publication as an important resource for the practising clinician in the field. It provides practical, scholarly, and evidence-based coverage of the full spectrum of clinical nephrology, written by a global faculty of experts.

The most relevant and important reference to clinical nephrology, this is an authoritative and comprehensive textbook combining the clinical aspects of renal disease essential to daily clinical practice with extensive information about the underlying basic science and current evidence available. Each section of the textbook has been critically and comprehensively edited under the auspices of a leading expert in the field.

This new edition has been significantly expanded and reapportioned to reflect developments and new approaches to topics, and includes treatment algorithms to aid and enhance patient care where possible. The fourth edition offers increased focus on the medical aspects of transplantation, HIV-associated renal disease, and infection and renal disease, alongside entirely new sections on genetic topics and clinical and physiological aspects of fluid/electrolyte and tubular disorders. The emphasis throughout is on marrying advances in scientific research with clinical management.

Richly illustrated throughout in full colour, this is a truly modern and attractive edition which reinforces the Oxford Textbook of Clinical Nephrology's position as an indispensable reference work of consistent quality and reliability. Enriched and refined by careful revision, this new edition continues the tradition of excellence.

Table of Contents


VOLUME 1
Part 1: Assessment of the patient with renal disease
1. Epidemiology of kidney disease, Aminu K. Bello, Marcello Tonelli, and Kitty J. Jager
2. Clinical assessment of the patient with renal disease, Chris Winearls
3. Presentations of renal disease, Chris Winearls
4. Kidney disease focused history taking, Chris Winearls
5. Kidney disease focused features on examination, Chris Winearls
6. Urinalysis, Walter P. Mutter
7. Assessment of renal function, Walter P. Mutter
8. Tubular function, Walter P. Mutter
9. Renal radiology: overview, Michael Weston
10. Ionising radiation and radiation protection, Jeannette Kathrin and Peter Howells
11. Plain radiography, excretion radiography, and contrast radiography, Akira Kawashima and Andrew J. LeRoy
12. Intervention, Steven Kennish
13. Ultrasound, Toby Wells and Simon Freeman
14. Computed tomography, Eugene Teoh and Michael Weston
15. Magnetic Resonance Imaging, Kazuhiro Kitajima, Akira Kawashima. and James F Glockner
16. Radioisotopes in diagnostic imaging in nephrology, Ramya Dhandapani and Sobhan Vinjamuri
17. Immunological investigation of the patient with renal disease, Jo H.M. Berden and Jack Wetzels
18. The renal biopsy, Ian Roberts, Phil Mason and Agnes Fogo
19. Clinical trials- how and why in nephrology, Richard Haynes, Martin J Landry, William G Herrington, and Colin Baigent
Part 2: The patient with fluid, electrolyte, and renal tubular disorders
20. An overview of tubular function, Matthew A. Bailey
21. Sodium transport and balance: A key role for the distal nephron, Laurent Schild
22. Water homeostasis, David Marples and Soren Neilson
23. Potassium homeostasis, Alain Doucet and Gilles Crambert
24. Renal acid-base homeostasis, Carsten Wagner and Olivier Devuyst
25. Phosphate homeostasis, Heini Murer, Juerg Biber, and Carsten Wagner
26. Calcium homeostasis, Francesco Trepiccione and Gianni Capasso
27. Magnesium homeostasis, Pascal Houillier
28. Approach to the patient with hyponatraemia, Ewout Hoorn and Bob Zietse
29. Approach to the patient with hypernatraemia, Bob Zietse
30. Approach to the patient with oedema, Jean-Marie Krzesinski and Eric P. Cohen
31. Approach to the patient with salt-wasting, Detlef Bockenhauer and Robert Kleta
32. Approach to the patient with polyuria, Daniel Bichet
33. Clinical use of diuretics, David Ellison and Arohan R. Subramanya
34. Approach to the patient with hypo-/hyperkalaemia, Charles Wingo and I. David Weiner
35. Approach to the patient with metabolic acidosis or alkalosis, Mitch Halperin and Kamel Kamel
36. Approach to the patient with renal tubular acidosis, Stephen Walsh
37. Approach to the patient with hypercalcaemia, Dennis Jose Joseph and Theresa A. Guise
38. Approach to the patient with hypocalcaemia, Agnes Linglart and Anne-Sophie Lambert
39. Approach to the patient with hypo-/hyperphosphataemia, Judith Blaine, Hector Giral-Arnal, Sabina Jelen, and Moshe Levi
40. Approach to the patient with hypomagnesaemia, Martin Konrad and Karl Peter Schlingmann
41. Approach to the patient with renal Fanconi syndrome, glycosuria or aminoaciduria, Detlef Bockenhauer and Robert Kleta
Part 3: The patient with glomerular disease
42. The glomerulus and the concept of glomerulonephritis, Alexander Woywodt and Diana Chiu
43. The renal glomerulus - the structural basis of ultrafiltration, Marlies Elger and Wilhelm Kriz
44. Function of the normal glomerulus, Jean-Claude Dussaule, Martin Flamant, and Christos Chatziantoniou
45. Mechanisms of glomerular injury: overview, Neil Turner
46. The patient with haematuria, John Neary and Neil Turner
47. Loin pain haematuria syndrome, John Neary
48. Nutcracker syndrome and phenomenon, John Neary and Neil Turner
49. Exercise-related pseudonephritis, Neil Turner
50. Proteinuria, Neil Turner and Stewart Cameron
51. Postural proteinuria (Benign orthostatic proteinuria), Neil Turner
52. Nephrotic syndrome, Premil Rajakrishna, Stewart Cameron and Neil Turner
53. Pathophysiology of oedema in nephrotic syndrome, Neil Turner and Premil Rajakrishna
54. Idiopathic nephrotic syndrome: overview, Patrick Niaudet and Alain Meyrier
55. Minimal change disease: clinical features and diagnosis, Patrick Niaudet and Alain Meyrier
56. Minimal change disease: treatment and outcome, Patrick Niaudet and Alain Meyrier
57. Primary focal segmental glomerulosclerosis (FSGS): Clinical features and diagnosis, Patrick Niaudet and Alain Meyrier
58. Primary focal segmental glomerulosclerosis (FSGS): Treatment and outcome, Patrick Niaudet and Alain Meyrier
59. Pathogenesis of proteinuria in minimal change disease and FSGS, Patrick Niaudet and Alain Meyrier
60. Membranous glomerulonephritis: overview, Daniel Cattran and Heather Reich
61. Membranous glomerulonephritis: clinical features and diagnosis, Daniel Cattran and Heather Reich
62. Membranous glomerulonephritis: treatment and outcome, Daniel Cattran and Heather Reich
63. Secondary membranous glomerulonephritis, Daniel Cattran and Heather Reich
64. Membranous glomerulonephritis: pathogenesis, Daniel Cattran and Heather Reich
65. Immunoglobulin A nephropathy: overview, Kar Nen Lai and Sydney C. W. Tang
66. Immunoglobulin A nephropathy: clinical features, Kar Nen Lai and Sydney C. W. Tang
67. Immunoglobulin A nephropathy: diagnosis, Kar Nen Lai and Sydney C. W. Tang
68. Immunoglobulin A nephropathy: treatment and outcome, Kar Nen Lai and Sydney C. W. Tang
69. Immunoglobulin A nephropathy: pathogenesis, Kar Nen Lai and Sydney C. W. Tang
70. Crescentic (rapidly progressive) glomerulonephritis, Neil Turner
71. Anti-glomerular basement membrane disease: overview, Ciao Zhou, Neil Turner, and Ming-hui Zhao
72. Anti-glomerular basement membrane disease: clinical features and diagnosis, Ciao Zhou, Neil Turner, and Ming-hui Zhao
73. Anti-glomerular basement membrane disease: treatment and outcome, Ciao Zhou, Neil Turner, and Ming-hui Zhao
74. Antiglomerular basement membrane disease: pathogenesis, Ciao Zhou, Neil Turner, and Ming-hui Zhao
75. Alport post-transplant antiglomerular basement membrane disease, Neil Turner
76. Post-infectious glomerulonephritis: overview, Bernardo Rodriguez-Iturbe and Mark Haas
77. Post streptococcal glomerulonephritis, Bernardo Rodriguez-Iturbe and Mark Haas
78. Immunoglobulin A dominant post-infectious glomerulonephritis, Bernardo Rodriguez-Iturbe and Mark Haas
79. Glomerulonephritis associated with endocarditis, deep-seated infections and shunt nephritis, Bernardo Rodriguez-Iturbe and Mark Haas
80. Membranoproliferative glomerulonephritis and C3 glomerulopathy, T. Cook and Daniel Gale
81. Fibrillary and immunotactoid glomerulopathy, Stephen Korbet, Melvin M.Schwartz, and Edmund J. Lewis
82. Drug induced and toxic glomerulopathies, Alexander Woywodt and Diana Chiu
Part 4: The patient with interstitial disease
83. Acute tubulointerstitial nephritis: overview, Richard Baker and B.Chir
84. Drug-induced acute tubulointerstitial nephritis, Hassan Izzedine and Victor Gueutin
85. Other toxic acute tubulointerstitial nephritis, Gregory L. Braden and Benjamin J. Freda
86. Chronic tubulointerstitial nephritis: overview, Adalbert Schiller, Adrian Covic, and Liviu Segall
87. Drug-induced chronic tubulointerstitial nephritis, Hassan Izzedine and Victor Gueutin
88. Heavy metals-induced tubulointerstitial nephritis, Patrick C D'Haese, Benjamin Vervaet, and A Verhulst
89. Aristolochic acid nephropathy caused by ingestion of herbal medicinal products, Refik Gokmen and Graham Lord
90. Balkan endemic nephropathy, Milan Radovic and Adalbert Schiller
91. Radiation nephropathy, Lisa Phipps and David C. Harris
92. Urate nephropathy, D. H. Kang and M. Kanbay
93. Immune-mediated tubulointerstitial nephritis, Liviu Segall and Adrian Covic
Part 5: The patient with reduced renal function
94. Chronic kidney disease: definition, classification, and approach to management, Ashish Upadyhah, Lesley Inker, and Andrew Levey
95. Chronic kidney disease in the developed world, Morgan Grams and Josef Coresh
96. Chronic kidney disease in developing countries, LuXia Zhang and Haiyan Wang
97. Chronic kidney disease long-term outcomes: progression, death, cardiovascular disease, infections, and hospitalizations, M. Beaulieu, C. Weber, N. Zalunardo and Adeera Levin
98. Cardiovascular disease and chronic kidney disease: overview, David Goldsmith
99. Recommendations for management of high renal risk chronic kidney disease, Charles Ferro and Khai Ping Ng
100. Hypertension as a cause of chronic kidney disease: what is the evidence?, Teena Tandon and Rajiv Agarwal
101. Diet and the progression of chronic kidney disease, Juan Jesus Carrero, Xu Hong, and Bengt Lindholm
102. Lipid disorders of patients with chronic kidney disease, Alan Jardine and Rajan Patel
103. Smoking in chronic kidney disease, Stephan R. Orth
104. Analytical aspects of measurements and laboratory values in chronic and acute kidney disease, Edmund Lamb and Finlay MacKenzie
105. Effect of lifestyle modifications on patients with chronic kidney disease, Andrew Williams, Robert Fassett, Erin Howden, and Jeff Coombes
106. Malnutrition, obesity, and undernutrition in chronic kidney disease, Naveet Kumar, Peter McCulloch, Heather Henderson, and Beverly D. Cameron
107. Left ventricular hypertrophy in chronic kidney disease, Carmine Zoccali, Francesca Mallamaci, and Davide Bolignano
108. Sudden cardiac death in chronic kidney disease, Reza Hajhosseini, Kaivan Korvath, and David Goldsmith
109. Epidemiology of calcium, phosphate and PTH disturbances in chronic kidney disease, Patrick Biggar, Hansjoerg Rothe, and Markus Ketteler
110. The role of inflammation in chronic kidney disease, Juan Jesus Carrero and Peter Stenvinkel
111. Vascular stiffness in chronic disease - pathophysiology and implications, John Townend and Charles Ferro
112. Oxidative stress and its implications in chronic disease, Nostratoli Vaziri
113. Abnormal endothelial vasomotor and secretory function, Thimoteus Speer and Danilo Fliser
114. Endothelins and their antagonists in chronic kidney disease, Neeraj Dhaun and David Webb
115. Chronic kidney disease-mineral and bone disorder: overview, Stuart Sprague and Menaka Sarav
116. Imaging for detection of vascular disease in chronic kidney disease patients, Paulo Raggi and Luis D'Marco Gascon
117. Pathophysiology of chronic kidney disease - mineral and bone disorder, Alexandra Voinescu, Nadia Iqbal and Kevin Martin
118. Management of chronic kidney disease - mineral and bone disorder, Alexandra Voinescu, Kevin Martin, Nadia Iqbal, and David Goldsmith
119. Fibroblast growth factor 23, klotho, and phosphorus metabolism in chronic kidney disease, Orlando Gutierrez
120. Vascular calcification, Adrian Covic, Mugurel Apetrii, Luminita Voroneanu, and David Goldsmith
121. Fractures in patients with chronic kidney disease, Alastair Hutchison and Michael L. Picton
122. Spectrum of bone pathologies in chronic kidney disease, Stuart Sprague and James Pullman
123. Clinical aspects and overview of renal anaemia, Iain Macdougall
124. Erythropoiesis-stimulating agents in chronic kidney disease, Iain Macdougall and Jolanta Malyszko
125. Iron metabolism in chronic kidney disease, Jolanta Malyszko and Iain Macdougall
126. Iron management in renal anaemia, Iain Macdougall
127. Pleoitropic effects of Vitamin D, Kaivan Khavandi, Halima Amer, Sarah Withers, and Behdad Afzali
128. Immunity, Behdad Afzali and Claudia Kemper
129. The liver and chronic kidney disease, Fabrizio Fabrizi and Michel Jadoul
130. Gastroenterology and renal medicine, Rishi Goel, Kamal Patel, and Terry Wong
131. Cutaneous manifestations of end-stage renal disease (ESRD), Timur A. Galperin, Kieron S. Leslie, and Antonia J. Cronin
132. The patient with reduced renal function: endocrinology, Tomas Agustsson and Paul Carroll
133. Sexual dysfunction, Tomas Agustsson and Paul Carroll
134. Health related quality of life and the patient with chronic kidney disease, Fred Finkelstein and Susan Finkelstein
135. Coagulopathies in chronic kidney disease, Seema Shrivastava, Beverley Hunt, and Tony Dorling
136. Mechanisms of progression of chronic kidney disese- overview, Neil Turner
137. Proteinuria as a direct cause of progression, Jeremy Hughes
138. Nephron numbers and hyperfiltration as drivers of progression, Valerie Luyckx
139. Podocyte loss as a common pathway to chronic kidney disease, Wilhelm Kriz
140. Disordered scarring and failure of repair, Jeremy Duffield
141. Modality selection for renal replacement therapy, Raj Thuraisingham and Cormac Breen
142. Patient education and involvement in pre-dialysis management, Sue Cox and Nicola Thomas
143. Preparation for renal replacement therapy, Muh Geot Wong, Bruce A. Cooper, and Carol A. Pollock
144. Choices and considerations for in-centre versus home based renal replacement therapy, Karthik Tennankore and Chris Chan
145. Conservative care in advanced chronic kidney disease, Aine Burns and Fliss E.M. Murtagh
146. Palliative care in end stage renal disease, Katie Vinen, Fliss E.M. Murtagh, and Irene Higginson
147. Patient selection when resources are limited, Bernadette Thomas and Christopher Blagg
148. Acidosis in chronic kidney disease, Muhammad Magdi Yaqoob
VOLUME 2
Part 6: The patient with another primary diagnosis
149. The patient with diabetes mellitus, Luigi Gnudi, Giorgio Gentile, and Piero Ruggenenti
150. Kidney involvement in plasma cell dyscrasias, Pierre M. Ronco
151. The patient with cryoglobulinaemia, Fabrizio Fabrizi and Patrice Cacoub
152. The patient with amyloidosis, Helen J. Lachmann and Giampaolo Merlini
153. The patient with myeloma, Efstathios Kastritis and M. A. Dimopoulos
154. Light chain deposition disease, Dirk R. J. Kuypers and Morie A. Gertz
155. Other consequences from monoclonal immunoglobulins/fragments: Membranoproliferative Glomerulonephritis and Acquired Fanconi Syndrome, Fernardo Fervenza, S. Vincent Raj Kumar, and Sethi Sanjeev
156. The patient with sarcoidosis, Ravi Rajakaria and Muhammad Magdi Yaqoob
157. The patient with vasculitis- overview, David Jayne
158. The patient with vasculitis: pathogenesis, Peter Heeringa and Coen A. Stegeman
159. The patient with vasculitis: clinical aspects, Alan Salama
160. The patient with vasculitis: treatment and outcome, Lorraine Harper and David Jayne
161. The patient with systemic lupus erythematosus: overview and pathogenesis, Johan van der Vlag and Jo H.M. Berden
162. The patient with systemic lupus erythematosus: clinical features, investigations, and diagnosis, Marie Condon, Philippa Dodd, and Liz Lightstone
163. The patient with systemic lupus erythematosus: treatment and outcome, Frederic Houssiau
164. The patient with antiphospholipid syndrome with or without lupus, Bassam Alchi and David Jayne
165. The patient with scleroderma-systemic sclerosis, Aine Burns and Bernadette Lynch
166. The patient with rheumatoid arthritis, mixed connective tissue disease, polymyositis, Sjogren syndrome, or overlap syndrome, Lesley-Anne Bissell, Dwomoa Adu, and Paul Emery
167. The patient with sickle cell anemia, Jean-Philippe Haymann and Francois Lionnet
168. The obese patient (metabolic syndrome), Maarit Korkeila, Bengt Lindholm, and Peter Stenvinkel
169. The patient with hepatorenal syndrome, Andres Cardenas and Pere Gines
170. Kidney/ear syndromes, Paul Goodyer
171. Kidney/eye syndromes, Friederike Mackensen, Vedat Schwenger, and Heiko Billing
172. The patient with renal cell cancer, Tim Eisen
173. The patient with Wilms' tumour, Christopher D. Mitchell
174. The patient with haemolytic uraemic syndrome/thrombotic thrombocytopenic purpura, Marina Noris and Tim Goodship
Part 7: The patient with urinary tract infection
175. Urinary tract infection in the adult: overview, Neil Sheerin
176. Infection of the lower urinary tract, Ased Ali and Rob Pickard
177. Upper urinary tract infection, Mark Harber
178. Complicated urinary tract infection, Ased Ali and Rob Pickard
179. Urinary tract infection in a patient with a kidney transplant, Mark Harber
180. Urinary tract infection in infancy and childhood, Heather Lambert
181. Schistosomiasis: the parasite and the host, Rashad Barsoum
182. Schistosomiasis: clinical impact, Rashad Barsoum
Part 8: The patient with infections causing renal disease
183. Malaria, Vinay Sakhuja and Harbir Singh Kohli
184. Leishmaniasis and trypanosomiasis, Vinay Sakhuja and Harbir Singh Kohli
185. Hepatitis B, Marion Muche and Seema Baid-Agrawal
186. Hepatitis C, Fabrizio Fabrizi
187. HIV and renal disease, Saraladevi Naicker and Graham Paget
188. Hantaviral infections, Hung-Chun Chen and Jan Clement
189. Dengue and other viral haemorrhagic fevers, Jung-San Chang and Hung-Chun Chen
190. Yellow fever, severe acute respiratory syndrome virus, and H1N1 influenza infections, Norbert Lameire
191. Leptospirosis, Emmanuel A. Burdmann
192. Syphilis, Emmanuel A. Burdmann
193. Rickettsiosis, Emmanuel A. Burdmann and Vivekanand Jha
194. Schistosomiasis, Rashad S. Barsoum
195. Nematode infections, Raja Ramachandran and Vivekanand Jha
196. Mycobacterial infections: tuberculosis, John Eastwood, Catherine M. Corbishley, and John M. Grange
197. Mycobacterial infections: leprosy and environmental mycobacteria, John Eastwood, Catherine M. Corbishley, and John M. Grange
198. Renal involvement in other infections, Raja Ramachandran and Vivekanand Jha
Part 9: The patient with urinary stone disease
199. Epidemiology of nephrolithiasis, Eric Taylor and Gary Curhan
200. Approach to the patient with kidney stones, Bhavna Chopra and Stanley Goldfarb
201. Calcium stones, David A. Bushinsky and Orson Moe
202. Uric acid stones, Michel Daudon and Paul Jungers
203. Cystine stones, Michel Daudon and Paul Jungers
204. Cell biology of nephrocalcinosis/nephrolithiasis, Benjamin A. Vervaet and Marc E. De Broe
205. Medical management of nephrocalcinosis and nephrolithiasis, Bridget Sinnott, Naim Maalouf, Khashayar Sakhaee, and Orson W. Moe
206. Imaging and interventional treatment: urolithiasis from the surgeon's point of view, Gauthier Raynal and Olivier Traxer
Part 10: The patient with hypertension
207. The structure and function of renal blood vessels, Karlhans Endlich and Rodger Loutzenhiser
208. Regulation of vasomotor tone in the afferent and efferent arterioles, Karlhans Endlich and Rodger Loutzenhiser
209. Tubuloglomerular feedback and autoregulation of renal blood flow and glomerular filtration rate, Karlhans Endlich and Rodger Loutzenhiser
210. The kidney and control of blood pressure, O. Gonzalez-Albarrana and Luis M. Ruilopeb
211. The effect of hypertension on renal vasculature and structure, Ulrich Wenzel, Thorsten Wiech, and Udo Helmchen
212. Ischaemic nephropathy, Helen Alderson, Constantina Chrysochou, James Ritchie, and Philip Kalra
213. Renal artery stenosis: clinical features and diagnosis, James Ritchie, Darren Green, Constantina Chrysochou, and Philip Kalra
214. Renal artery stenosis: diagnosis, James Ritchie, Darren Green, Constantina Chrysochou, and Philip Kalra
215. Renal artery stenosis: management and outcome, James Ritchie, Darren Green, Constantina Chrysochou, and Philip Kalra
216. Malignant hypertension, Caroline Whitworth and Stewart Fleming
217. Resistant hypertension, David Webb and Ian MacIntyre
218. The hypertensive child, Wolfgang Rascher
219. Treatment of hypertension in children, Wolfgang Rascher
Part 11: The patient with acute kidney injury (and critical care nephrology)
220. Definitions, classification, epidemiology, and risk factors of acute kidney injury, Eric AJ Hoste and John A. Kellum
221. Pathophysiology of acute kidney injury, Michael S. Goligorsky and Julien Maizel (with contributions by R Vasko, M Rabadi, and B Ratliff)
222. Clinical approach to the patient with acute kidney injury: diagnosis and differential diagnosis, Norbert Lameire, Raymond Vanholder and Wim Van Biesen
223. The role of novel biomarkers in acute kidney injury, Norbert Lameire
224. Prevention of acute kidney injury: overview, Norbert Lameire
225. Prevention of acute kidney injury: non-pharmacological strategies, Norbert Lameire
226. Prevention of acute kidney injury: pharmacological strategies, Norbert Lameire
227. Prevention of acute kidney injury: drug- and nephrotoxin-induced acute kidney injury, Norbert Lameire
228. Non-dialytic management of the patient with acute kidney injury, Achim Jorres, Dietrich Hasper, and Michael Oppert
229. Fluid overload, Achim Jorres, Dietrich Hasper, and Michael Oppert
230. Electrolyte and acid-base disorders, Achim Jorres, Dietrich Hasper, and Michael Oppert
231. Coagulation disturbances, Achim Jorres, Dietrich Hasper, and Michael Oppert
232. Renal replacement therapy in the patient with acute kidney injury: overview, Jang Won Seo and Ravindra L. Mehta
233. Intermittent acute renal replacement therapy, Mark R Marshall
234. Continuous renal replacement therapy, Miet Schetz and Andrew Davenport
235. Peritoneal dialysis in acute kidney injury, Wim Van Biesen
236. Scoring systems in acute kidney injury patients, Angel Candela, Teresa Tenorio, Aurora Lietor, and Fernando Liano
237. Short and long-term overall outcome and renal prognosis of AKI, Norbert Lameire, Wim Van Biesen, and Raymond Vanholder
238. Overall and renal prognosis of AKI, Norbert Lameire
239. Acute kidney injury in children, Alexander Fichtner and Franz Schaefer
240. Acute kidney injury in the elderly, Dinna N. Cruz, Anna Clementi, and Mitchell H. Rosner
241. Acute kidney injury in the tropics, Vivekanand Jha
242. Acute kidney injury and hantavirus disease, Jan Clement and Piet Maes
243. Community-acquired pneumonia and acute kidney injury, Norbert Lameire
244. Acute kidney injury in severe sepsis, John Prowle and Rinaldo Bellomo
245. Cardiovascular surgery and acute kidney injury, Jeremiah R. Brown and Chirag R. Parikh
246. Contrast-induced acute kidney injury, Douglas Stewart, Gaurav Shah, Jeremiah R. Brown, and Peter A. McCullough
247. Renal failure in cirrhosis: pathogenesis, diagnosis, and treatment, Vicente Arroyo, Monica Guevara, and Javier Fernandez
248. Acute kidney injury in heart failure, Dinna N. Cruz, Anna Giuliani, and Claudio Ronco
249. Acute kidney injury in pulmonary diseases, Soo Young Yoon and Ravindra L. Mehta
250. Acute kidney injury in pregnancy, Duska Dragun and Bjorn Hegner
251. Acute kidney injury in the cancer patient, Gilbert W. Moeckel, Veena Manjunath, and Mark A. Perazella
252. Acute kidney injury in polytrauma and rhabdomyolysis, Mehmet Sukru Sever and Raymond Vanholder
253. Acute kidney injury in patients with severe burn injury, Nele Brusselaers and Eric AJ Hoste
VOLUME 3
Part 12: The patient on dialysis
254. Uraemic toxins: overview, Griet Glorieux, Nathalie Neirynck, Anneleen Pletinck, Eva Schepers, and Raymond Vanholder
255. Haemodialysis: overview, Jonathan Himmelfarb
256. Haemodialysis: vascular access, Michael Allon
257. Haemodialysis: principles, Claudio Ronco and William R. Clark
258. Haemodialysis: prescription and assessment of adequacy, Scott D. Bieber and Jonathan Himmelfarb
259. Hemodialysis: acute complications, Victor F. Seabra and Bertrand L. Jaber
260. Haemofiltration and haemodiafiltration, Francesco Locatelli, Celestina Manzoni, and Giuseppe Pontoriero
261. Dialysis withdrawal and palliative care, Arkadiy Pinkhasov, Michael J Germain, and Lewis M. Cohen
262. Frequent haemodialysis, Alan S. Kliger and Rita Suri
263. Peritoneal dialysis: overview, Rajnish Mehrotra and Jonathan Himmelfarb
264. Peritoneal dialysis: principles and peritoneal physiology, Joanna Stachowska-Pietka, Jacek Waniewski, and Bengt Lindholm
265. Peritoneal dialysis: adequacy and prescription management, Anjali Bhatt Saxena
266. Peritoneal dialysis: non-infectious complications, Sara Dunsmore and Joanne Bargman
267. Overview of dialysis patient management and future directions, Allen R. Nissenson, John Moran, and Robert Provenzano
268. Cardiovascular complications in end-stage renal disease patients: pathophysiological aspects, Gerard M. London
269. Bacterial and fungal infections in patients on haemodialysis, Laura Labriola, Michel Jadoul, and Eric Goffin
270. Bacterial and fungal infections in patients on peritoneal dialysis, Laura Labriola, Michel Jadoul, and Eric Goffin
271. Virus infections in patients on dialysis, Laura Labriola, Michel Jadoul, and Eric Goffin
272. Cognitive function, depression, and psychosocial adaptation, Manjula Kurella Tamura, Mark L. Unruh, and Ea Wha Kang
273. Volume assessment and management in dialysis, Rajiv Agarwal
274. Nutritional screening and nutritional management in dialysis patients, Carla Maria Avesani, Juan Jesus Carrero, Bengt Lindholm, and Peter Stenvinkel
Part 13: The transplant patient
275. The evolution of kidney transplantation, Peter J Morris and Jeremy R Chapman
276. Pre-transplant assessment of the recipient, Christophe Legendre
277. Organ donation, Thomas Mone
278. Donor and recipient kidney transplantation surgery, Richard DM Allen and Henry CC Pleass
279. Immunology, sensitization, and histocompatibility, Thangamani Muthukumar, Darshana Dadhania, Choli Hartono, Manikkam Suthanthiran, and Choli Hartono
280. Immediate post-transplant care and surgical complications, Simon R Knight and Rutger J Ploeg
281. Immunosuppression, drugs, and protocols, Dirk R J Kuypers and Maarten Naesens
282. Renal transplant imaging, Simon Gruenewald and Philip Vladica
283. Rejection, David N. Rush and Peter W. Nickerson
284. Infection: prophylaxis, diagnosis, and management, Camille Nelson Kotton
285. Cardiovascular disease: prophylaxis, diagnosis, and management, Emily P McQuarrie, Hallvard Holdaas, Bengt Fellstrom, and Alan G Jardine
286. Chronic allograft dysfunction, L.K. Henderson, B.J. Nankivell, and J.R. Chapman
287. Cancer after kidney transplantation, Germaine Wong and Angela C Webster
288. Metabolic bone disease: prophylaxis, diagnosis, and management, Grahame J Elder
289. Recurrent renal disease: prophylaxis, diagnosis, and management, Philip Clayton and Steven Chadban
290. Paediatric renal transplantation, Minnie M. Sarwal and Ron Shapiro
Part 14: Renal disease at different stages of life
291. Growth and development, Lesley Rees
292. The adolescent with renal disease: transition to adult services, Stephen D Marks
293. Contraception in patients with kidney disease, Kate Wiles and Catherine Nelson-Piercy
294. Pregnancy and renal physiology, Kate Bramham and Catherine Nelson-Piercy
295. Pregnancy in patients with chronic kidney disease and on dialysis, Kate Bramham and Catherine Nelson-Piercy
296. Pre-eclampsia and related disorders, Kate Wiles and Catherine Nelson-Piercy
297. Acute renal disease in pregnancy, Kate Wiles and Catherine Nelson-Piercy
298. Specific renal conditions in pregnancy, Kate Bramham and Catherine Nelson-Piercy
299. Pregnancy after renal transplantation, Kate Bramham and Catherine Nelson-Piercy
300. The kidney in ageing: biology, anatomy, physiology, and clinical relevance, Richard J. Glassock and Andrew D. Rule
Part 15: The patient with genetic renal disease
301. Ethical aspects of genetic testing, Frances Flinter
302. Antenatal diagnosis and pre-implantation genetic testing, Frances Flinter
303. The molecular basis of ciliopathies and cyst formation, Wolfgang Kuhn and Gerd Walz
304. The adult with renal cysts, Yves Pirson and Olivier Devuyst
305. The child with renal cysts, Carsten Bergmann, N. Ortis-Bruchle, V. Frank, and Klaus Zerres
306. Autosomal dominant polycystic kidney disease: overview, Albert CM Ong and Richard Sandford
307. Autosomal dominant polycystic kidney disease: clinical features, Albert CM Ong and Timothy Ellam
308. Autosomal dominant polycystic kidney disease: diagnosis, Richard Sandford
309. Autosomal dominant polycystic kidney disease: management (including strategies to slow progression), Young-Hwan Hwang and York Pei
310. Management of intracranial aneurysms, Yves Pirson and Dominique Chauveau
311. Management of cystic liver disease, Joost Drenth and Tom Gevers
312. Autosomal dominant polycystic kidney disease in children and young adults, Carsten Bergmann and Klaus Zerres
313. Autosomal recessive polycystic kidney disease, Carsten Bergmann and Klaus Zerres
314. Bardet-Biedl syndrome and other ciliopathies, Lukas Foggensteiner and Philip Beales
315. Hepatocyte nuclear factor-1B, Coralie Bingham
316. Nephronophthisis and medullary cystic kidney disease: overview, John A Sayer
317. Nephronophthisis, John A Sayer and Roslyn J Simms
318. Medullary cystic kidney disease and other autosomal dominant inherited interstitial kidney diseases, John A Sayer
319. Oral-facial-digital type 1 syndrome, Brunella Franco
320. The molecular basis of glomerular basement membrane disorders, Rachel Lennon and Neil Turner
321. Alport syndrome: overview, Laurence Heidet, Bertrand Knebelmann, and Marie Claire Gubler
322. Alport syndrome: clinical features, Laurence Heidet, Bertrand Knebelmann, and Marie Claire Gubler
323. Alport syndrome: diagnosis, Laurence Heidet, Bertrand Knebelmann, and Marie Claire Gubler
324. Alport syndrome: management, Laurence Heidet, Bertrand Knebelmann, and Marie Claire Gubler
325. Thin glomerular basement membrane nephropathy and other collagenopathies, Laurence Heidet, Bertrand Knebelmann, and Marie Claire Gubler
326. Nail patella syndrome, Laurence Heidet and Marie Claire Gubler
327. Molecular basis of nephrotic syndrome, Moin A. Saleem and Corinne Antignac
328. Molecular basis of renal tumour syndromes, Tom Connor and Patrick Maxwell
329. WT1 and its disorders, Nick Hastie and Eve Miller-Hodges
330. Tuberous sclerosis complex renal disease, Bradley P. Dixon, J. Christopher Kingswood, and John J. Bissler
331. Hypoxia-inducible factor and renal disorders, Tom Connor and Patrick Maxwell
332. Von Hippel-Lindau disease, Tom Connor and Patrick Maxwell
333. Molecular basis of complement-mediated renal disease, Nicholas Medjeral-Thomas, Anna Richards, and Matthew C. Pickering
334. Inherited metabolic diseases and the kidney, Robin Lachmann and Elaine Murphy
335. Fabry disease: overview and pathophysiology, Stephen Waldek
336. Fabry disease: clinical features, Stephen Waldek
337. Fabry disease: diagnosis, Stephen Waldek
338. Fabry disease: management and outcome, Stephen Waldek
339. Cystinosis, Elena N. Levtchenko and Mirian C. Janssen
340. Mitochondrial diseases and the kidney, Andrew Hall and Shamima Rahman
341. APOL1 and renal disease, Neil Turner, Teena Tandon, and Rajiv Agarwal
342. MYH9 and renal disease, Neil Turner and Bertrand Knebelmann
Part 16: The patient with structural and congenital abnormalities
343. Human kidney development, Paul Winyard
344. Kidney stem cells, Oren Pleniceanu and Benjamin Dekel
345. Anatomical types of congenital anomalies: overview of obstruction, Michiel Schreuder
346. Renal agenesis, Michiel Schreuder
347. Renal dysplasia, Michiel Schreuder
348. Renal hypoplasia, Michiel Schreuder
349. Normal variation in nephron numbers, Michiel Schreuder
350. Renal tubular dysgenesis, Michiel Schreuder
351. Congenital solitary functioning kidney, Michiel Schreuder
352. Duplex, ectopic, and horseshoe kidneys, Michiel Schreuder
353. Pelviureteric junction obstruction and megaureter, Michiel Schreuder
354. Posterior urethral valves, Michiel Schreuder
355. Vesicoureteric reflux and reflux nephropathy, Heather Lambert
356. The patient with urinary tract obstruction, Muhammad M. Yaqoob, Katherine Bennett-Richards, and Islam Junaid
357. Retroperitoneal fibrosis, Muhammad M. Yaqoob, Katherine Bennett-Richards, and Islam Junaid
358. Branchio-oto-renal syndrome, Udo Vester and Stefanie Weber
359. Townes-Brocks syndrome, Udo Vester and Stefanie Weber
360. Renal coloboma syndrome, Udo Vester and Stefanie Weber
361. Ante- and postnatal imaging to diagnose human kidney malformations, Fred E. Avni, Marie Cassart, Anne Massez, and Michele Hall
Part 17: Drugs and renal disease
362. Drug-induced nephropathies, Anushree Shirali and Mark A. Perazella
363. Drug dosing in chronic kidney disease, Ali J. Olyaei, Ted A. Foster, and Edgar V. Lerma
364. Drug dosing in acute kidney injury, Thomas A. Golper, Andrew A. Udy, and Jeffrey Lipman

Rewards Program

Write a Review